The current valuation score of Processa Pharmaceuticals Inc is 7.10, ranking 266 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.51, which is -99.03% below the recent high of -0.01 and -2876.53% above the recent low of -15.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.